NK cells are required for dendritic cell-based immunotherapy at the time of tumor challenge.
Bouwer AL, Saunderson SC, Caldwell FJ, Damani TT, Pelham SJ, Dunn AC, Jack RW, Stoitzner P, McLellan AD. NK cells are required for dendritic cell-based immunotherapy at the time of tumor challenge. J Immunol. 2014 Mar 01; 192(5):2514-21.
-
Animals
-
Animals
-
Antigen Presentation
-
Antigen Presentation
-
Antigens, Neoplasm
-
Antigens, Neoplasm
-
Cancer Vaccines
-
Cancer Vaccines
-
CD4-Positive T-Lymphocytes
-
CD4-Positive T-Lymphocytes
-
CD8-Positive T-Lymphocytes
-
CD8-Positive T-Lymphocytes
-
Dendritic Cells
-
Dendritic Cells
-
Immunity, Cellular
-
Immunity, Cellular
-
Interferon-gamma
-
Interferon-gamma
-
Killer Cells, Natural
-
Killer Cells, Natural
-
Mice
-
Mice
-
Mice, Inbred BALB C
-
Mice, Inbred BALB C
-
Mice, Knockout
-
Mice, Knockout
-
Neoplasms
-
Neoplasms
-
Pore Forming Cytotoxic Proteins
-
Pore Forming Cytotoxic Proteins
-
Vaccination
-
Vaccination